GSK Annual Report 2002
GSK Annual Report 2002
GSK Annual Report 2002
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
86 GlaxoSmithKline Notes to the financial statements<br />
6 Segment information<br />
An analysis of turnover, profit before taxation, total assets, net assets and tangible fixed assets by business and geographical sector are set<br />
out below. The business sectors consist of Pharmaceuticals (prescription pharmaceuticals and vaccines) and Consumer Healthcare (oral care,<br />
OTC medicines and nutritional healthcare). The geographical sectors reflect the Group’s most significant regional markets and are consistent<br />
with the Group’s regional market management reporting structure. Business sector data includes an allocation of corporate costs to the sector.<br />
There are no sales between business sectors.<br />
The Group’s activities are organised on a global basis. The geographical sector figures are therefore influenced by the location of the<br />
Group’s operating resources, in particular manufacturing and research, and by variations over time in intra-Group trading and funding<br />
arrangements.<br />
2001 2000<br />
<strong>2002</strong> (restated) (restated)<br />
Turnover by business sector £m £m £m<br />
Pharmaceuticals 17,995 17,205 15,429<br />
Consumer Healthcare 3,217 3,284 2,650<br />
External turnover 21,212 20,489 18,079<br />
Profit before tax by business sector<br />
Pharmaceuticals 5,068 4,302 4,316<br />
Consumer Healthcare 483 432 413<br />
Operating profit 5,551 4,734 4,729<br />
Share of profits/(losses) of joint ventures and associated undertakings 75 71 57<br />
Profit on disposal of interest in associate – 96 144<br />
Profit on disposal of businesses 10 – –<br />
Product divestments 11 (296) 1,402<br />
Merger transaction costs – – (121)<br />
Net interest payable (141) (88) (182)<br />
Profit before taxation 5,506 4,517 6,029<br />
Profit before taxation 5,506 4,517 6,029<br />
Taxation (1,461) (1,333) (1,747)<br />
Minority interests (110) (97) (120)<br />
Preference share dividends (20) (34) (56)<br />
Earnings 3,915 3,053 4,106<br />
Total assets by business sector<br />
Pharmaceuticals 18,608 18,495<br />
Consumer Healthcare 3,719 3,848<br />
Total assets 22,327 22,343<br />
Net assets by business sector<br />
Pharmaceuticals 5,720 6,573<br />
Consumer Healthcare 1,668 1,679<br />
Net assets 7,388 8,252
Change language